← Open Payments lookup

CHRISTOPHER CARSON: Open Payments

NPI 1578986915 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$534 in 16 payments from 7 companies in 2025. Trend: 2023 $125 · 2024 $222 · 2025 $534

Food & beverage: $534
CompanyPaymentsAmount
Novo Nordisk Inc4$170
Otsuka America Pharmaceutical, Inc.3$155
Alkermes, Inc.3$80
Axsome Therapeutics, Inc.3$75
Vanda Pharmaceuticals Inc.1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20
E.R. Squibb & Sons, L.L.C.1$14

Products named: Ozempic, ABILIFY MAINTENA, Auvelity, ARISTADA, REXULTI, LYBALVI, FANAPT, CAPLYTA.

Industry payments across MS — which companies pay providers there.